Cargando…
Identification of human erythrocyte blood group antigens on decay- accelerating factor (DAF) and an erythrocyte phenotype negative for daf
Decay accelerating factor (DAF) is a glycoprotein present on the surfaces of many types ofcells in contact with plasma, including erythrocytes, leukocytes, and platelets (reviewed in reference 1). A small amount of DAF is also present in serum. Numerous investigators have demonstrated that DAF inhib...
Autores principales: | Telen, MJ, Hall, SE, Green, AM, Moulds, Rosse |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189670/ https://www.ncbi.nlm.nih.gov/pubmed/2455016 |
Ejemplares similares
-
The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb
Publicado: (1987) -
Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas.
por: Koretz, K., et al.
Publicado: (1992) -
Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids
Publicado: (1987) -
Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes
Publicado: (1984) -
Effects of Lycium barbarum Polysaccharides on Health and Aging of C. elegans Depend on daf-12/daf-16
por: Zhang, Zhaokang, et al.
Publicado: (2019)